Possible neuroleptic malignant syndrome associated with paliperidone.
Duggal
Harpreet S
HS
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003402:Creatine Kinase / Q000097:blood; D005260:Female; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009127:Muscle Rigidity / Q000139:chemically induced / Q000503:physiopathology; D009459:Neuroleptic Malignant Syndrome / Q000503:physiopathology*; D000068882:Paliperidone Palmitate; D011569:Psychiatric Status Rating Scales; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000150:complications / Q000188:drug therapy; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D007555:Isoxazoles; D011743:Pyrimidines; D003402:Creatine Kinase; D000068882:Paliperidone Palmitate